Abstract
Hypertrophic cardiomyopathy (HCM) is the most common autosomal dominant inherited cardiac disease with great genetic and clinical heterogeneity. Pregnancy is usually tolerated well, with complications limited to high-risk and symptomatic women. Preconception counseling and risk management are important, because of the inheritance risk and the determination of follow-up during pregnancy. Vaginal delivery is generally preferred, because of the reduced risk of blood loss and infection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ACE:
-
Angiotensin converting enzyme
- ARBs:
-
Angiotensin receptor blockers
- FDA:
-
Food and Drug Administration
- G+:
-
Genotype positive
- HCM:
-
Hypertrophic cardiomyopathy
- ICD:
-
Implantable cardioverter defibrillator
- LV:
-
Left ventricular
- LVOT:
-
Left ventricular outflow tract
- NYHA:
-
New York Heart Association
- SCD:
-
Sudden cardiac death
- VKA:
-
Vitamin K antagonist
- WHO:
-
World Health Organization
References
Elliott PM, Anastasakis A, Borger MA et al (2014) 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy. Eur Heart J 35:2733–2779
Semsarian C, Ingles J, Maron MS et al (2015) New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol 65:1249–1254
Maron BJ, Ommen SR, Semsarian C et al (2014) Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. J Am Coll Cardiol 64:83–99
Olivotto I, Cecchi F, Poggesi C et al (2012) Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging. Circ Heart Fail 5:535–546
Jensen MK, Havndrup O, Christiaensen M, Andersen PS, Diness B, Axelsson A et al (2013) Penetrance of hypertrophic cardiomyopathy in children and adolescents. Circulation 127:48–54
Michels M, Soliman OI, Kofflard MJ, Hoedemaekers YM, Dooijes D, Majoor-Krakauer D et al (2009) Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations. JACC Cardiovasc Imaging 2:58–64
Maron MS, Olivotto I, Betocchi et al (2003) Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl Med 348:295–303
O’Mahony C, Jichi F, Pavlou M et al (2014) A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). Eur Heart J 35:2010–2020
Guttmann OP, Rahman MS, O’Mahony C et al (2014) Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review. Heart 100:465–472
Gersh BJ, Maron BJ, Bonow RO et al (2011) 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 124(24):e783–e831
Maron MS, Olivotto I, Zenovich A et al (2006) Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 114(21):2232–2239
Wigle ED, Sasson Z, Henderson MA et al (1985) Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. Prog Cardiovasc Dis 28:1–83
Regitz-Zagrosek V, Blomstrom LC, Borghi C et al (2011) ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 32:3147–3197
Autore C, Conte MR, Piccininno (2002) Risk associated with pregnancy in hypertrophic cardiomyopathy. J Am Coll Cardiol 40:1864–1869
Thaman R, Varnava A, Hamid MS et al (2003) Pregnancy related complications in women with hypertrophic cardiomyopathy. Heart 89:752–756
Siu SC, Sermer M, Colman JM et al (2001) Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 104(5):515–521
Drenthen W, Boersma E, Balci A et al (2010) Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J 31:2124–2132
Silversides CK, Harris L, Haberer K et al (2006) Recurrence rates of arrhythmias during pregnancy in women with previous tachyarrhythmias and impact on fetal and neonatal outcomes. Am J Cardiol 97(8):1206–1212
Lima V, Parikh P, Zhu J et al (2015) Association of cardiomyopathy with adverse cardiac events in pregnant women at the time of delivery. J Am Coll Cardiol HF 3:257–266
Krul SPJ, van der Smagt JJ, van de Berg MP, Sollie KM, Pieper PG, van Spaendonck-Zwarts (2011) Systematic review of pregnancy in women with inherited cardiomyopathies. Eur J Heart Fail 13:584–594
Balci A, Sollie-Szarynska KM, van der Bijl et al (2014) Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease. Heart 100:1373–1381
Stergiopoulous K, Shiang E, Bench T (2011) Pregnancy in patients with pre-existing cardiomyopathies. J Am Coll Cardiol 58:337–350
Christiaans I, Birnie E, Bonsel GJ, Mannens MM, Michels M, Majoor-Krakauer D et al (2011) Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy. Eur Heart J 32:1161–1170
Maron BJ, Zipes DP (2005) 36th Bethesda conference: eligibility recommendations for competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol 45:1312–1375
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Michels, M. (2017). Pregnancy in Hypertrophic Cardiomyopathy. In: Roos-Hesselink, J., Johnson, M. (eds) Pregnancy and Congenital Heart Disease. Congenital Heart Disease in Adolescents and Adults. Springer, Cham. https://doi.org/10.1007/978-3-319-38913-4_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-38913-4_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-38911-0
Online ISBN: 978-3-319-38913-4
eBook Packages: MedicineMedicine (R0)